Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases

D Phaneuf, N Wakamatsu, JQ Huang… - Human molecular …, 1996 - academic.oup.com
D Phaneuf, N Wakamatsu, JQ Huang, A Borowski, AC Peterson, SR Fortunato, G Ritter…
Human molecular genetics, 1996academic.oup.com
We have generated mouse models of human Tay-Sachs and Sandhoff diseases by targeted
disruption of the Hexa (α subunit) or Hexb (β subunit) genes, respectively, encoding
lysosomal β-hexosaminidase A (structure, α) and B (structure, ββ). Both mutant mice
accumulate GM2 ganglioside in brain, much more so in Hexb−/− mice, and the latter also
accumulate glycolipid GA2. Hexa−/− mice suffer no obvious behavioral or neurological
deficit, while Hexb−/− mice develop a fatal neurodegenerative disease, with spasticity …
Abstract
We have generated mouse models of human Tay-Sachs and Sandhoff diseases by targeted disruption of the Hexa (α subunit) or Hexb (β subunit) genes, respectively, encoding lysosomal β-hexosaminidase A (structure, α) and B (structure, ββ). Both mutant mice accumulate GM2 ganglioside in brain, much more so in Hexb −/− mice, and the latter also accumulate glycolipid GA2. Hexa −/− mice suffer no obvious behavioral or neurological deficit, while Hexb −/− mice develop a fatal neurodegenerative disease, with spasticity, muscle weakness, rigidity, tremor and ataxia. The Hexb −/− but not the Hexa −/− mice have massive depletion of spinal cord axons as an apparent consequence of neuronal storage of GM2. We propose that Hexa −/− mice escape disease through partial catabolism of accumulated GM2 via GA2 (asialo-GM2) through the combined action of sialidase and β-hexosaminidase B.
Oxford University Press